HTScan® PDGF Receptor alpha Kinase Assay Kit #7767
Inquiry Info. # 7767
Please see our recommended alternatives.
Product Information
Specificity / Sensitivity
Background
Description: The kit provides a means of performing enzymatic assays with active human PDGFR-alpha kinase. It includes active PDGFR-alpha kinase (supplied as a GST fusion protein), a biotinylated substrate peptide and a phospho-tyrosine monoclonal antibody for detection of the phosphorylated form of the substrate peptide.
Unit Definition: 10 Units is defined as the amount of PDGFR-alpha kinase required to maximally phosphorylate 75 pmol of FLT3 (Tyr589) biotinylated substrate peptide (#1305) in 30 minutes at 25ºC in a total reaction volume of 50 ul quantified by DELFIA® to achieve signal/background=25 or greater.
Peptide Core Sequence: NEY*FY*V
Molecular Weights: Peptide substrate, Biotin-FLT3 (Tyr589): 1,945 Daltons, GST-PDGFR-alpha Kinase domain: 87,851 Daltons
Storage: Antibodies are supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 ug/ml BSA and 50% glycerol. Do not aliquot the antibodies. Peptides are supplied at 6 uM in 0.001% DMSO carbonate buffer solution (3 mM Na2CO3, 7mM NaHCO3, PH9.6). Enzymes are supplied in 50 mM Tris-HCL (pH 8.0), 100 mM NaCl, 5 mM DTT, 15 mM reduced glutathione and 20% glycerol. Store at -80ºC.
Keep enzymes on ice during use.
Avoid repeated freeze-thaw cycles.
Amount of kinase: GST-PDGFR-alpha10 Units/50 ul.
- Deuel, T.F. et al. (1988) Biofactors 1, 213-217.
- Bergsten, E. et al. (2001) Nat. Cell Biol. 3, 512-516.
- Betsholtz, C. et al. (2001) Bioessays 23, 494-507.
- Coughlin, S.R. et al. (1988) Prog. Clin. Biol. Res. 266, 39-45.
- Ostman, A. and Heldin, C.H. (2001) Adv. Cancer Res. 80, 1-38.
- Panayotou, G. et al. (1992) EMBO J. 11, 4261-4272.
- Ramalingam, K. et al. (1995) Bioorg. Med. Chem. 3, 1263-1272.
- Kashishian, A. et al. (1992) EMBO J. 11, 1373-1382.
Alternate Names
enzyme; high throughput; HTS; kinase assay; PDGF; PDGFR; PDGFRA; Tyrosine kinase
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.